CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Wash IP +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04740892
NCT04740892N/ACompleted

A Clinical Evaluation of the Safety and Efficacy of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children

Johnson & Johnson Consumer Inc. (J&JCI)·interventional·Posted Feb 5, 2021·Updated Feb 6, 2024

In Brief

A clinical study evaluating Wash IP and Cream IP for Dermatitis, Atopic. Completed, enrolled 31 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the effectiveness (assessed by clinical evaluation of eczema/atopic dermatitis severity and parent-perceived benefits) and tolerability (assessed by clinical grading and parent-perception) of the investigational cream when used in conjunction with a baby wash in babies, toddlers, and children with mild to moderate atopic dermatitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 5, 2021
Enrollment StartJan 21, 2021
Primary CompletionFeb 6, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 5.4 years ago

Interventions

Wash IPother

Parent participant will bathe the child participant with the investigational wash at least 3 times per week, but no more than once daily, for 4 weeks.

Cream IPother

Parent participant will apply the investigational cream on their child participant twice daily for 4 weeks.